BRPI0808410A2 - Métodos e composições para normalizar secreções da glândula meibomiana - Google Patents

Métodos e composições para normalizar secreções da glândula meibomiana

Info

Publication number
BRPI0808410A2
BRPI0808410A2 BRPI0808410-6A BRPI0808410A BRPI0808410A2 BR PI0808410 A2 BRPI0808410 A2 BR PI0808410A2 BR PI0808410 A BRPI0808410 A BR PI0808410A BR PI0808410 A2 BRPI0808410 A2 BR PI0808410A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
meibomian gland
gland secretions
normalizing
Prior art date
Application number
BRPI0808410-6A
Other languages
English (en)
Inventor
George W Ousler Iii
Matthew J Chapin
Mark B Abelson
George Minno
Aron Shapiro
Original Assignee
Aciex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aciex Therapeutics Inc filed Critical Aciex Therapeutics Inc
Publication of BRPI0808410A2 publication Critical patent/BRPI0808410A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0808410-6A 2007-02-28 2008-02-28 Métodos e composições para normalizar secreções da glândula meibomiana BRPI0808410A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90420907P 2007-02-28 2007-02-28
PCT/US2008/002762 WO2008106228A2 (en) 2007-02-28 2008-02-28 Methods and compositions for normalizing meibomian gland secretions

Publications (1)

Publication Number Publication Date
BRPI0808410A2 true BRPI0808410A2 (pt) 2015-06-23

Family

ID=39462102

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808410-6A BRPI0808410A2 (pt) 2007-02-28 2008-02-28 Métodos e composições para normalizar secreções da glândula meibomiana

Country Status (9)

Country Link
US (1) US20080312194A1 (pt)
EP (1) EP2131809A2 (pt)
JP (1) JP2010520210A (pt)
CN (1) CN101668511A (pt)
AU (1) AU2008219600A1 (pt)
BR (1) BRPI0808410A2 (pt)
CA (1) CA2679448A1 (pt)
MX (1) MX2009009207A (pt)
WO (1) WO2008106228A2 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8950405B2 (en) 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US20090043365A1 (en) 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20080114423A1 (en) 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US7981095B2 (en) 2005-07-18 2011-07-19 Tearscience, Inc. Methods for treating meibomian gland dysfunction employing fluid jet
US8083787B2 (en) 2005-07-18 2011-12-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US8128673B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US8137390B2 (en) 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8128674B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
JP5894364B2 (ja) * 2007-08-16 2016-03-30 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド 眼および付属器組織の炎症を処置するための治療組成物
USD613408S1 (en) 2008-02-06 2010-04-06 Tearscience, Inc. Eye treatment head gear
USD617443S1 (en) 2008-02-06 2010-06-08 Tearscience, Inc. Eye treatment goggles
AU2010256652B2 (en) * 2009-06-05 2015-11-26 Allergan, Inc. Artificial tears and therapeutic uses
USD638128S1 (en) 2009-10-06 2011-05-17 Tearscience, Inc. Ocular device design
HUE046071T2 (hu) * 2009-10-30 2020-01-28 Intratus Inc Eljárások és készítmények gyógyszerek elnyújtott hatóanyagleadására
EP2523556A4 (en) * 2010-01-11 2013-08-28 Gtx Inc METHOD FOR TREATING MIBROMED DYNAMIC FUNCTION
EP2591041A4 (en) * 2010-07-11 2013-11-27 Univ Arkansas COMPOSITIONS AND METHODS FOR INCREASING SLIP RATE AND EARLY POWER OF POULTRY
CN103249402A (zh) * 2010-10-08 2013-08-14 赫尔普百治疗有限公司 新组合物
US20120093876A1 (en) * 2010-10-13 2012-04-19 Aciex, Inc. Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
HUE049489T2 (hu) 2011-12-07 2020-09-28 Allergan Inc Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával
RU2625301C2 (ru) * 2011-12-23 2017-07-13 Юниверсити Ов Уэстерн Сидни Офтальмологическая композиция
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
MX361886B (es) 2012-05-08 2018-12-18 Nicox Ophthalmics Inc Preparaciones de agentes terapéuticos hidrófobos, métodos de elaboración y uso de los mismos.
EP2869819A4 (en) * 2012-07-09 2016-03-09 Holden Brien Vision Inst COMPOSITIONS, METHODS AND / OR DEVICES FOR THE PREVENTION AND / OR TREATMENT OF OCULAR DROUGHT DISORDERS
US10842670B2 (en) 2012-08-22 2020-11-24 Johnson & Johnson Vision Care, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
ES2942724T3 (es) 2013-04-30 2023-06-06 Alcon Inc Sistemas para el tratamiento de enfermedades del ojo
EP3015107B1 (en) * 2013-06-28 2019-08-28 Keio University Agent for treating meibomian gland dysfunction
WO2015134673A1 (en) * 2014-03-04 2015-09-11 The Trustees Of Columbia University In The City Of New York Method for treating ocular inflammation
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
CN107205929B (zh) * 2015-02-02 2022-06-24 参天制药股份有限公司 多泡沫体及其眼睑施用
CN113144203A (zh) * 2015-09-28 2021-07-23 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
US10974063B2 (en) 2016-06-30 2021-04-13 Alcon Inc. Light therapy for eyelash growth
WO2019005139A1 (en) * 2017-06-30 2019-01-03 Jenivision Inc. FORMULATIONS FOR HAIR GROWTH
CN109689161A (zh) 2016-08-19 2019-04-26 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物
JP7311160B2 (ja) * 2017-08-18 2023-07-19 アクリビスタ エルエルシー ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
MX2020005155A (es) * 2017-11-21 2020-08-20 Axerovision Inc Composiciones y metodos de uso para tratar inflamacion aberrante en glandulas secretoras perioculares o en la superficie ocular.
JP6904289B2 (ja) * 2018-03-19 2021-07-14 ライオン株式会社 水性眼科用組成物
US10933111B2 (en) 2019-01-08 2021-03-02 Boston Biotechnology US CORP Treating dry eye disorders
CN115279458A (zh) 2020-01-10 2022-11-01 阿祖拉眼科有限公司 组合物和敏感性说明
WO2022026805A1 (en) * 2020-07-31 2022-02-03 Altaire Pharmaceuticals, Inc. Ophthalmic compositions for removing meibum or inhibiting meibum buildup
AU2021381495A1 (en) 2020-11-23 2023-06-22 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye
FR3131214A1 (fr) * 2021-12-23 2023-06-30 Laboratoires Thea Composition topique et son applicateur, destines a soulager le chalazion

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2804421A (en) * 1951-04-24 1957-08-27 American Cyanamid Co Tetracycline type antibiotic ointment
US3642987A (en) * 1969-12-23 1972-02-15 Malcolm E Bergy Lincomycin and tetracycline compositions
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US5149694A (en) * 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
WO1992003133A1 (en) * 1990-08-16 1992-03-05 Bloom, Leonard Topical treatment of blepharitis
DK1075265T3 (da) * 1998-05-08 2006-06-26 Univ Miami Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
JP3677421B2 (ja) * 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
WO2002089743A2 (en) * 2001-05-09 2002-11-14 The Regents Of The University Of Michigan Use of compositions for treating rosacea
WO2003005971A2 (en) * 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
US6488646B1 (en) * 2001-09-12 2002-12-03 Unilever Home & Personal Care Usa Swab deliverable actives
US6494856B1 (en) * 2001-09-12 2002-12-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Swab deliverable actives
JP2005523313A (ja) * 2002-04-16 2005-08-04 コッラジェネックス ファーマシューチカルス インコーポレイテッド 目の酒さ及び酒さ性ざ瘡の同時治療方法
ES2301964T3 (es) * 2003-01-21 2008-07-01 Senju Pharmaceutical Co., Ltd. Preparado liquido acuoso que contiene acido 2-amino-3-(4-bromobenzoil)fenilacetico.
PL2204168T3 (pl) * 2003-04-07 2015-06-30 Supernus Pharmaceuticals Inc Preparaty tetracyklin do jedorazowego dziennego podawania
ES2435398T3 (es) * 2004-04-08 2013-12-19 Eye Co Pty Ltd. Tratamiento de retinopatía exudativa con mineralocorticoides
WO2008097851A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tetracycline compositions for topical administration

Also Published As

Publication number Publication date
WO2008106228A2 (en) 2008-09-04
AU2008219600A1 (en) 2008-09-04
EP2131809A2 (en) 2009-12-16
MX2009009207A (es) 2010-02-12
WO2008106228A3 (en) 2009-03-12
JP2010520210A (ja) 2010-06-10
CA2679448A1 (en) 2008-09-04
US20080312194A1 (en) 2008-12-18
CN101668511A (zh) 2010-03-10

Similar Documents

Publication Publication Date Title
BRPI0808410A2 (pt) Métodos e composições para normalizar secreções da glândula meibomiana
BRPI0815353A2 (pt) Compoições e dhea para o tratamento da menopausa
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0818732A2 (pt) Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0807918A2 (pt) composições e método para preservação de tecido
BRPI0820980A2 (pt) Composições e métodos para detecção de tiabs
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BRPI0811752A2 (pt) Aparelho para tratar gás
BRPI0818736A2 (pt) composições e métodos para intensificar imunorrepostas à bactéria flagelada
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
ATE526567T1 (de) Zusammensteller und zusammenstellungsverfahren
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI1006229A2 (pt) composição incluindo uma quantidade suficiente de curcumina
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0811430A2 (pt) Composições anti-insônia e processos
BRPI0911580A2 (pt) composições para o tratamento de uma condição artrítica
BRPI0815330A2 (pt) métodos e composições para tratar cânceres
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
BRPI0820413A2 (pt) Polinucleotídeos e métodos para o melhoramento de plantas
BRPI0810207A2 (pt) Métodos e composições para o tratamento de câncer
BRPI0917562A2 (pt) composições farmacêuticas e métodos para estabilizar as mesmas
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.